DMAX Insider Trading Activity and SEC Form 4 Filings
DMAX insider trading summary
No open-market insider purchases or sales of DiaMedica Therapeutics Inc. (DMAX) have been reported on SEC Form 4 in the past 12 months.
Latest DMAX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 16, 2022 | Dietrich John Pauls | President and CEO | Buy | $24K (20,000 @ $1.21) |
| Jan 20, 2006 | C Fred Toney | 10% Owner | Sell | $1.1M (1,000,000 @ $1.07) |
| Jan 3, 2006 | C Fred Toney | 10% Owner | Sell | $39K (33,440 @ $1.15) |
| Jan 3, 2006 | C Fred Toney | 10% Owner | Buy | $467 (400 @ $1.17) |
| Nov 21, 2005 | Edgardo A Mercadante | CEO & President | Buy | $140 (100 @ $1.40) |
| Nov 21, 2005 | Edgardo A Mercadante | CEO & President | Buy | $4K (2,700 @ $1.35) |
| Nov 21, 2005 | Edgardo A Mercadante | CEO & President | Buy | $6K (3,900 @ $1.42) |
| Nov 21, 2005 | Edgardo A Mercadante | CEO & President | Buy | $4K (3,100 @ $1.37) |
| Nov 21, 2005 | Edgardo A Mercadante | CEO & President | Buy | $282 (200 @ $1.41) |
| Sep 30, 2005 | Edgardo A Mercadante | CEO & President | Buy | $6K (3,100 @ $1.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.